Literature DB >> 29200205

Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

Zhuohao He1, Jing L Guo1, Jennifer D McBride1, Sneha Narasimhan1, Hyesung Kim1, Lakshmi Changolkar1, Bin Zhang1, Ronald J Gathagan1, Cuiyong Yue2, Christopher Dengler2, Anna Stieber1, Magdalena Nitla1, Douglas A Coulter2,3, Ted Abel4, Kurt R Brunden1, John Q Trojanowski1, Virginia M-Y Lee1.   

Abstract

Alzheimer's disease (AD) is characterized by extracellular amyloid-β (Aβ) plaques and intracellular tau inclusions. However, the exact mechanistic link between these two AD lesions remains enigmatic. Through injection of human AD-brain-derived pathological tau (AD-tau) into Aβ plaque-bearing mouse models that do not overexpress tau, we recapitulated the formation of three major types of AD-relevant tau pathologies: tau aggregates in dystrophic neurites surrounding Aβ plaques (NP tau), AD-like neurofibrillary tangles (NFTs) and neuropil threads (NTs). These distinct tau pathologies have different temporal onsets and functional consequences on neural activity and behavior. Notably, we found that Aβ plaques created a unique environment that facilitated the rapid amplification of proteopathic AD-tau seeds into large tau aggregates, initially appearing as NP tau, which was followed by the formation and spread of NFTs and NTs, likely through secondary seeding events. Our study provides insights into a new multistep mechanism underlying Aβ plaque-associated tau pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29200205      PMCID: PMC5760353          DOI: 10.1038/nm.4443

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  39 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Authors:  Adam J Schwarz; Peng Yu; Bradley B Miller; Sergey Shcherbinin; James Dickson; Michael Navitsky; Abhinay D Joshi; Michael D Devous; Mark S Mintun
Journal:  Brain       Date:  2016-03-02       Impact factor: 13.501

3.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

4.  Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.

Authors:  Yvonne S Eisele; Ulrike Obermüller; Götz Heilbronner; Frank Baumann; Stephan A Kaeser; Hartwig Wolburg; Lary C Walker; Matthias Staufenbiel; Mathias Heikenwalder; Mathias Jucker
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

5.  Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months.

Authors:  David L King; Gary W Arendash
Journal:  Physiol Behav       Date:  2002-04-15

6.  Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Authors:  Michiyo Iba; Jing L Guo; Jennifer D McBride; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

7.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.

Authors:  Peng Yuan; Carlo Condello; C Dirk Keene; Yaming Wang; Thomas D Bird; Steven M Paul; Wenjie Luo; Marco Colonna; David Baddeley; Jaime Grutzendler
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

8.  Single App knock-in mouse models of Alzheimer's disease.

Authors:  Takashi Saito; Yukio Matsuba; Naomi Mihira; Jiro Takano; Per Nilsson; Shigeyoshi Itohara; Nobuhisa Iwata; Takaomi C Saido
Journal:  Nat Neurosci       Date:  2014-04-13       Impact factor: 24.884

9.  Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.

Authors:  Tristan Bolmont; Florence Clavaguera; Melanie Meyer-Luehmann; Martin C Herzig; Rebecca Radde; Matthias Staufenbiel; Jada Lewis; Mike Hutton; Markus Tolnay; Mathias Jucker
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

10.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

View more
  159 in total

1.  Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.

Authors:  Sarah L DeVos; Bianca T Corjuc; Caitlin Commins; Simon Dujardin; Riley N Bannon; Diana Corjuc; Benjamin D Moore; Rachel E Bennett; Mehdi Jorfi; Jose A Gonzales; Patrick M Dooley; Allyson D Roe; Rose Pitstick; Daniel Irimia; Matthew P Frosch; George A Carlson; Bradley T Hyman
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

Review 2.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

3.  Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Authors:  Atsushi Aoyagi; Carlo Condello; Jan Stöhr; Weizhou Yue; Brianna M Rivera; Joanne C Lee; Amanda L Woerman; Glenda Halliday; Sjoerd van Duinen; Martin Ingelsson; Lars Lannfelt; Caroline Graff; Thomas D Bird; C Dirk Keene; William W Seeley; William F DeGrado; Stanley B Prusiner
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

Review 4.  Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.

Authors:  Garrett S Gibbons; Virginia M Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 5.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 6.  What is strain in neurodegenerative diseases?

Authors:  Ye Tian; Lanxia Meng; Zhentao Zhang
Journal:  Cell Mol Life Sci       Date:  2019-09-17       Impact factor: 9.261

7.  A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

Authors:  Nicolas R Barthélemy; Yan Li; Nelly Joseph-Mathurin; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; Richard J Perrin; Alison M Goate; John C Morris; Celeste M Karch; Chengjie Xiong; Ricardo Allegri; Patricio Chrem Mendez; Sarah B Berman; Takeshi Ikeuchi; Hiroshi Mori; Hiroyuki Shimada; Mikio Shoji; Kazushi Suzuki; James Noble; Martin Farlow; Jasmeer Chhatwal; Neill R Graff-Radford; Stephen Salloway; Peter R Schofield; Colin L Masters; Ralph N Martins; Antoinette O'Connor; Nick C Fox; Johannes Levin; Mathias Jucker; Audrey Gabelle; Sylvain Lehmann; Chihiro Sato; Randall J Bateman; Eric McDade
Journal:  Nat Med       Date:  2020-03-11       Impact factor: 53.440

Review 8.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

9.  Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.

Authors:  Michael A Metrick; Natalia do Carmo Ferreira; Eri Saijo; Andrew G Hughson; Allison Kraus; Christina Orrú; Michael W Miller; Gianluigi Zanusso; Bernardino Ghetti; Michele Vendruscolo; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

Review 10.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.